Posts Tagged ‘NIH News’

New NIH application guidelines: Changes to appendix and post-submission materials policies

NIH has released an updated application guide that includes two significant policy changes effective Jan. 25, 2017. 1) As we reported earlier this year, most appendix materials for applications have been eliminated. The only materials you may submit in the appendix section are: For applications proposing clinical trials (unless the FOA provides other instructions for these materials): Clinical trial protocols Investigator’s brochure from Investigational New Drug (IND), as appropriate For all applications: Blank informed consent/assent … Read More

New resources to support diversity in NIH-funded research

The NIH has developed a new portal to information about how scientific workforce diversity is promoted and supported in extramural programs. The website focuses on four main areas: Background on NIH initiatives in support of scientific workforce diversity Resources for scientific leadership & faculty members to use to further diversity in their programs Resources for investigators and trainees to develop their careers, find training and mentorship, and learn about others’ careers through personal stories and … Read More

Reminder: What’s new with peer review? First panel discussion this Thursday

You’re invited to hear a panel discussion with OHSU faculty who are currently serving on NIH study sections to learn about best practices for grant writing–and especially what they’re seeing in grants they’re reviewing with respect to the new requirements on rigor and reproducibility and more. Among other things, they will discuss guidance they’ve received from NIH as reviewers, as well as how study sections are responding. Bring your questions! This week’s session will be held: Thursday, … Read More

New federal policies issued on clinical trials

The NIH is the largest funder of clinical trials in the U.S., investing over $3 billion each year. Standards for scientific rigor and ethical oversight must be exceptionally high because the health and safety of human subjects are at stake. But challenges in the design, efficiency, and reporting of clinical trials are well documented–and may even threaten the progress of biomedicine. In a recent JAMA article,  Kathy Hudson, Ph.D., deputy director for Science, Outreach and Policy … Read More

Learn more about NIH peer review in upcoming online briefings

Have you ever wondered what goes on inside an NIH Study Section and what’s most important to reviewers? The NIH Center for Scientific Review is hosting a series of online briefings in November and December to help you navigate the peer review process and increase your chances of getting funded. The first two briefings will provide fellowship and R01 grant applicants  information on how applications are reviewed for scientific and technical merit. The third briefing will offer information to … Read More

The NIH takes on the challenge of reproducibility: new requirements for 2016

Coming this fall, you will see changes to application instructions for NIH grant applications. Advances in science are built upon previous observations and findings: that’s why replication and corroboration of research results are essential to the scientific process. In response to continued failures in the reliability and reproducibility of published research, the NIH has been analyzing possible causes and exploring potential interventions for some time. A series of pilot projects were run over the past … Read More

NIH seeks additional input on how to sustain the biomedical research enterprise, neuroscience research funding

In recent months, NIH has issued requests for information on various initiatives, resources, and ongoing projects. On April 2,  Jon Lorsch, director of the National Institute of General Medical Sciences, and NIH Deputy Director for Extramural Research Sally Rockey solicited a request titled “Input on Strategies for Optimizing the Impact and Sustainability of Biomedical Research.” Lorsch and Rockey are heading two NIH-wide working groups focused on maximizing the impact and sustainability of NIH-funded research. Rockey’s … Read More

NCI director Harold Varmus to step down

In case you haven’t heard, Harold Varmus, M.D., announced yesterday that he will be stepping down from his position as director of NIH’s National Cancer Institute, effective Mar. 31, 2015. Varmus has led the NCI for nearly five years, and is leaving to pursue scientific work in New York City. In a letter to NCI staff, he outlines some of  NCI’s accomplishments during his tenure, advancements in cancer research, and his future plans.

Notice: NIH revises definition of “clinical trial”

The revision is designed to make the distinction between clinical trials and clinical research studies clearer and to enhance the precision of the information NIH collects, tracks, and reports on clinical trials.  It is not intended to expand the scope of the category of clinical trials. No changes have been made to the NIH definition of a “Phase III clinical trial.” The revised NIH definition of “clinical trial” is: A research study1  in which one … Read More

NIH clarifies the 4-year limit for K99 postdoctoral applicants

The NIH has released a Notice of Clarification in regards to PA-12-042 “NIH Pathway to Independence Award (Parent K99/R00).” The purpose the Notice is to clarify the eligibility requirement that K99 applicants must have no more than 4 years of postdoctoral research experience at the time of the initial application or resubmission or revision.  Specifically, this Notice describes situations in which time is not counted against the 4-year limit. The modified eligibility section now reads: … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives